Aethir vs Mira — how do they compare? Aethir trades at Rp66.14 (market cap Rp1,34T, Rp95,78M 24h volume), while Mira trades at Rp698.2 (market cap Rp224,51M, Rp102,44M 24h volume). The key difference: Aethir is far larger — about 5968.6× Mira's market cap, and Aethir's circulating supply is 20,1B / 42B ATH (48%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Aethir for 39 Days and Mira for 22 Days on average.
| ATH | MIRA | |
|---|---|---|
Market Cap | Rp1,34T | Rp224,51M |
Volume (24h) | Rp95,78M | Rp102,44M |
Circulating Supply | 20,1B / 42B ATH (48%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 39 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
Aethir (ATH) is currently trading at Rp69.199 with a market cap of Rp1.41T, showing bearish technical signals with 18 sell indicators versus 5 buy signals. The token trades near key support at Rp69, with oscillators neutral and mixed RSI readings. With 48% of max supply in circulation and average hold time of 39 days, the token shows moderate distribution. Recent market sentiment appears cautious as technical indicators point to potential downward pressure.
Overall outlook remains cautious with bearish technical dominance. Key opportunity lies in oversold RSI_6 at 29.53 suggesting potential bounce, while major risks include continued selling pressure and lack of strong fundamental catalysts. Investors should monitor support at Rp66-69 levels closely for potential entry points.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
Aethir is best described as distributed cloud compute infrastructure. It aggregates enterprise-grade GPU chips into a single global network to increase the supply of on-demand cloud compute resources for the AI, gaming, and virtualized compute sectors.
Read more on ATH →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →